128 related articles for article (PubMed ID: 11605050)
1. Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines.
Nakayama K; Miyazaki K; Kanzaki A; Fukumoto M; Takebayashi Y
Oncol Rep; 2001; 8(6):1285-7. PubMed ID: 11605050
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.
Nakayama K; Kanzaki A; Terada K; Mutoh M; Ogawa K; Sugiyama T; Takenoshita S; Itoh K; Yaegashi N; Miyazaki K; Neamati N; Takebayashi Y
Clin Cancer Res; 2004 Apr; 10(8):2804-11. PubMed ID: 15102688
[TBL] [Abstract][Full Text] [Related]
3. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
[TBL] [Abstract][Full Text] [Related]
4. Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.
Nakayama K; Kanzaki A; Ogawa K; Miyazaki K; Neamati N; Takebayashi Y
Int J Cancer; 2002 Oct; 101(5):488-95. PubMed ID: 12216079
[TBL] [Abstract][Full Text] [Related]
5. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
[TBL] [Abstract][Full Text] [Related]
6. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) in human hepatocellular carcinoma.
Sugeno H; Takebayashi Y; Higashimoto M; Ogura Y; Shibukawa G; Kanzaki A; Terada K; Sugiyama T; Watanabe K; Katoh R; Nitta Y; Fukushima T; Koyama Y; Inoue N; Sekikawa K; Ogawa K; Sato Y; Takenoshita S
Anticancer Res; 2004; 24(2C):1045-8. PubMed ID: 15154620
[TBL] [Abstract][Full Text] [Related]
7. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
Komatsu M; Sumizawa T; Mutoh M; Chen ZS; Terada K; Furukawa T; Yang XL; Gao H; Miura N; Sugiyama T; Akiyama S
Cancer Res; 2000 Mar; 60(5):1312-6. PubMed ID: 10728692
[TBL] [Abstract][Full Text] [Related]
8. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin.
Miyashita H; Nitta Y; Mori S; Kanzaki A; Nakayama K; Terada K; Sugiyama T; Kawamura H; Sato A; Morikawa H; Motegi K; Takebayashi Y
Oral Oncol; 2003 Feb; 39(2):157-62. PubMed ID: 12509969
[TBL] [Abstract][Full Text] [Related]
9. Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.
Kanzaki A; Toi M; Neamati N; Miyashita H; Oubu M; Nakayama K; Bando H; Ogawa K; Mutoh M; Mori S; Terada K; Sugiyama T; Fukumoto M; Takebayashi Y
Jpn J Cancer Res; 2002 Jan; 93(1):70-7. PubMed ID: 11802810
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinomas.
Kanzaki A; Nakayama K; Miyashita H; Shirata S; Nitta Y; Oubu M; Higashimoto M; Mutoh M; Mori S; Konno S; Ogawa K; Toi M; Takebayashi Y
Anticancer Res; 2003; 23(2C):1913-5. PubMed ID: 12820478
[TBL] [Abstract][Full Text] [Related]
12. Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma.
Higashimoto M; Kanzaki A; Shimakawa T; Konno S; Naritaka Y; Nitta Y; Mori S; Shirata S; Yoshida A; Terada K; Sugiyama T; Ogawa K; Takebayashi Y
Int J Mol Med; 2003 Mar; 11(3):337-41. PubMed ID: 12579336
[TBL] [Abstract][Full Text] [Related]
13. ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl.
Xu W; Cai B; Chen JL; Li LX; Zhang JR; Sun YY; Wan XP
Int J Gynecol Cancer; 2008; 18(4):718-22. PubMed ID: 17944925
[TBL] [Abstract][Full Text] [Related]
14. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a prognostic factor in human endometrial carcinoma.
Aida T; Takebayashi Y; Shimizu T; Okamura C; Higasimoto M; Kanzaki A; Nakayama K; Terada K; Sugiyama T; Miyazaki K; Ito K; Takenoshita S; Yaegashi N
Gynecol Oncol; 2005 Apr; 97(1):41-5. PubMed ID: 15790435
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
[TBL] [Abstract][Full Text] [Related]
16. Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells.
Katano K; Safaei R; Samimi G; Holzer A; Tomioka M; Goodman M; Howell SB
Clin Cancer Res; 2004 Jul; 10(13):4578-88. PubMed ID: 15240550
[TBL] [Abstract][Full Text] [Related]
17. The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells.
Katano K; Safaei R; Samimi G; Holzer A; Rochdi M; Howell SB
Mol Pharmacol; 2003 Aug; 64(2):466-73. PubMed ID: 12869652
[TBL] [Abstract][Full Text] [Related]
18. miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression.
Wang X; Zhu W; Zhao X; Wang P
Int J Mol Med; 2016 Jun; 37(6):1636-42. PubMed ID: 27121102
[TBL] [Abstract][Full Text] [Related]
19. Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma.
Ohbu M; Ogawa K; Konno S; Kanzaki A; Terada K; Sugiyama T; Takebayashi Y
Cancer Lett; 2003 Jan; 189(1):33-8. PubMed ID: 12445675
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.
Dmitriev OY
Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
